Bicer C - Search Results

1

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.

Osiyemi O, Yasin S, Zorrilla C, Bicer C, Hillewaert V, Brown K, Crauwels HM. Osiyemi O, et al. Among authors: bicer c. Infect Dis Ther. 2018 Mar;7(1):147-159. doi: 10.1007/s40121-017-0184-8. Epub 2018 Jan 15. Infect Dis Ther. 2018. PMID: 29335895 Free PMC article.

2

Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen.

Brown K, Thomas D, McKenney K, Reeder M, Simonson RB, Bicer C, Nettles RE, Crauwels H. Brown K, et al. Among authors: bicer c. Clin Pharmacol Drug Dev. 2019 May;8(4):541-548. doi: 10.1002/cpdd.632. Epub 2018 Dec 3. Clin Pharmacol Drug Dev. 2019. PMID: 30508308 Clinical Trial.

3

Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen.

Crauwels HM, Osiyemi O, Zorrilla C, Bicer C, Brown K. Crauwels HM, et al. Among authors: bicer c. HIV Med. 2019 May;20(5):337-343. doi: 10.1111/hiv.12721. Epub 2019 Mar 14. HIV Med. 2019. PMID: 30873741 Free article. Clinical Trial.

4

Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.

Girard PM, Antinori A, Arribas JR, Ripamonti D, Bicer C, Netzle-Sveine B, Hadacek B, Moecklinghoff C. Girard PM, et al. Among authors: bicer c. HIV Med. 2017 Jan;18(1):5-12. doi: 10.1111/hiv.12386. Epub 2016 Jun 9. HIV Med. 2017. PMID: 27279571 Free article. Clinical Trial.

5

Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV.

Munderi P, Were E, Avihingsanon A, Mbida PAM, Mohapi L, Moussa SB, Jansen M, Bicer C, Mohammed P, van Delft Y. Munderi P, et al. Among authors: bicer c. South Afr J HIV Med. 2019 Jul 23;20(1):949. doi: 10.4102/sajhivmed.v20i1.949. eCollection 2019. South Afr J HIV Med. 2019. PMID: 31392036 Free PMC article.

6

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications.

Marra F, Höner Zu Siederdissen C, Khoo S, Back D, Schlag M, Ouwerkerk-Mahadevan S, Bicer C, Lonjon-Domanec I, Jessner W, Beumont-Mauviel M, Kalmeijer R, Cornberg M. Marra F, et al. Among authors: bicer c. Br J Clin Pharmacol. 2018 May;84(5):961-971. doi: 10.1111/bcp.13519. Epub 2018 Feb 21. Br J Clin Pharmacol. 2018. PMID: 29345798 Free PMC article.

7

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

Asselah T, Moreno C, Sarrazin C, Gschwantler M, Foster GR, Craxí A, Buggisch P, Sanai F, Bicer C, Lenz O, Van Dooren G, Nalpas C, Lonjon-Domanec I, Schlag M, Buti M. Asselah T, et al. Among authors: bicer c. PLoS One. 2017 Jan 5;12(1):e0168713. doi: 10.1371/journal.pone.0168713. eCollection 2017. PLoS One. 2017. PMID: 28056030 Free PMC article. Clinical Trial.

8

Analysis of neurocognitive function and CNS endpoints in the PROTEA trial: darunavir/ritonavir with or without nucleoside analogues.

Clarke A, Johanssen V, Gerstoft J, Clotet B, Ripamonti D, Murungi A, Bicer C, Hadacek MB, Moecklinghoff C. Clarke A, et al. Among authors: bicer c. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19526. doi: 10.7448/IAS.17.4.19526. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394035 Free PMC article.

9

Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa.

Steele AD, Madhi SA, Louw CE, Bos P, Tumbo JM, Werner CM, Bicer C, De Vos B, Delem A, Han HH. Steele AD, et al. Among authors: bicer c. Pediatr Infect Dis J. 2011 Feb;30(2):125-30. doi: 10.1097/INF.0b013e3181f42db9. Pediatr Infect Dis J. 2011. PMID: 20842070 Clinical Trial.

10

Clinical Bridging Studies and Modeling Approach for Implementation of a Patient Centric Sampling Technique in Padsevonil Clinical Development.

Kramer H, Bicer C, Otoul C, Rospo C, Macpherson M, Watling M, Bani M, Sciberras D, Chanteux H. Kramer H, et al. Among authors: bicer c. AAPS J. 2023 Nov 16;26(1):1. doi: 10.1208/s12248-023-00866-7. AAPS J. 2023. PMID: 37973662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters